Most research-grade blends use a 1:1 ratio (equal milligram amounts of each peptide), but custom ratios like 2:1 or 3:2 are available from some compounding facilities depending on research objectives
Sotzny F, Filgueiras IS, Kedor C, Freitag H, Wittke K, Bauer S, et al
I 2 = 87.9%)
The researchers evaluated electronic health records from a global health research network (Trinetx) dating from 2004 to 2024
Insurance prior authorization for GLP-1 medications is a process where insurance companies require approval before covering the cost of these treatments
Key Educational Points: Emphasize the experimental nature No clinical trials support this combination Highlight individual compound efficacy Both peptides show strong effects as monotherapies Discuss approved alternatives CagriSema and other studied combinations offer evidence-based options Explain regulatory status Neither compound has FDA approval for metabolic applications as of 2026 Address safety concerns Overlapping side effect profiles create legitimate risks When clients express interest in research peptides, directing them toward compounds with established safety profiles and dosing protocols serves their best interests